ClinicalTrials.Veeva

Menu

Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops (KALICORT)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Corticosteroid
Corneal Graft Disorder (Disorder)

Treatments

Device: use of the KaliJAR box

Study type

Observational

Funder types

Other

Identifiers

NCT04107246
19CH145
2019-A02280-57 (Other Identifier)

Details and patient eligibility

About

Following corneal graft, local steroids with a gradually decreasing dose for 12 months are prescribed to reduce the graft rejection risk (maximum incidence of 20% for the first 12 months). The validated KaliJAR® device is a box for single-dose eye drops collection. This innovative tool will make it possible to objectify the compliance of patients with a corneal graft.

Unlike the field of glaucoma, no specific compliance data are available for corneal grafts, although it is important because graft rejection is the most important cause of corneal graft failure.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newly transplanted corneal patients
  • Patients able to instill correctly topical corticosteroid treatment
  • Patients able to come to control visits
  • Patient affiliated or entitled to a social security system
  • Patient informed about the study and having signed a consent

Exclusion criteria

  • Patients under guardianship
  • Patients unable to give their consent or to correctly use the collection box

Trial design

30 participants in 1 patient group

Newly transplanted corneal patients
Treatment:
Device: use of the KaliJAR box

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems